A novel Bcl-2 homology domain-3 (BH3) mimetic1. Inhibits primary acute myeloid leukemia (AML) progenitor cell proliferation (IC50=0.18 µM) and induces apoptosis in primary AML cells (IC50= 3.6 µM)2. Synergizes with other agents such as chloroquine3 and c
* VAT and and shipping costs not included. Errors and price changes excepted
